ESTINYL Drug Patent Profile
✉ Email this page to a colleague
When do Estinyl patents expire, and when can generic versions of Estinyl launch?
Estinyl is a drug marketed by Schering and is included in one NDA.
The generic ingredient in ESTINYL is ethinyl estradiol. There is one drug master file entry for this compound. Additional details are available on the ethinyl estradiol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ESTINYL?
- What are the global sales for ESTINYL?
- What is Average Wholesale Price for ESTINYL?
Summary for ESTINYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 86 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,257 |
| DailyMed Link: | ESTINYL at DailyMed |
Recent Clinical Trials for ESTINYL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 2 |
US Patents and Regulatory Information for ESTINYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | ESTINYL | ethinyl estradiol | TABLET;ORAL | 005292-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Schering | ESTINYL | ethinyl estradiol | TABLET;ORAL | 005292-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Schering | ESTINYL | ethinyl estradiol | TABLET;ORAL | 005292-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
